| 000 | 01801 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515050212.0 | ||
| 264 | 0 | _c20070723 | |
| 008 | 200707s 0 0 eng d | ||
| 022 | _a1520-7552 | ||
| 024 | 7 |
_a10.1002/dmrr.711 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLazar, L | |
| 245 | 0 | 0 |
_aHeat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study. _h[electronic resource] |
| 260 |
_bDiabetes/metabolism research and reviews _cMay 2007 |
||
| 300 |
_a286-91 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aC-Peptide _xblood |
| 650 | 0 | 4 | _aChaperonin 60 |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGastroenteritis _xchemically induced |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aInsulin _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPeptide Fragments |
| 650 | 0 | 4 |
_aPeptides _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aOfan, R | |
| 700 | 1 | _aWeintrob, N | |
| 700 | 1 | _aAvron, A | |
| 700 | 1 | _aTamir, M | |
| 700 | 1 | _aElias, D | |
| 700 | 1 | _aPhillip, M | |
| 700 | 1 | _aJosefsberg, Z | |
| 773 | 0 |
_tDiabetes/metabolism research and reviews _gvol. 23 _gno. 4 _gp. 286-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/dmrr.711 _zAvailable from publisher's website |
| 999 |
_c16695941 _d16695941 |
||